Gotham Asset Management LLC Cut Its Position in Gilead Sciences INC (GILD) by $17.38 Million

November 7, 2017 - By reb123z

Investors sentiment increased to 0.93 in 2017 Q2. Its up 0.02, from 0.91 in 2017Q1. It is positive, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. 8,000 are owned by Barbara Oil. Investors Asset Management Of Georgia Incorporated Ga Adv holds 10,877 shares or 0.53% of its portfolio. Paradigm Asset Mgmt Ltd Company owns 0% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 49,660 shares. Clark Estates Ny reported 44,750 shares. Newfocus Financial Gru Ltd reported 6,300 shares. Fulton Breakefield Broenniman Lc, a Maryland-based fund reported 79,389 shares. Great West Life Assurance Can reported 1.77 million shares. 119,780 were reported by Bain Cap Public Equity Management Limited Liability Com. Quadrant Capital Mngmt holds 1.23% or 22,298 shares in its portfolio. Arcadia Invest Mngmt Corporation Mi holds 0.02% or 1,100 shares. Fincl Bank Of Nova Scotia has invested 0.11% in Gilead Sciences, Inc. (NASDAQ:GILD). Boothbay Fund Mngmt Lc holds 8,670 shares or 0.13% of its portfolio. Robeco Institutional Asset Management Bv owns 450,827 shares or 0.21% of their US portfolio. Utd Serv Automobile Association stated it has 1.38 million shares or 0.3% of all its holdings. Neuberger Berman Grp Incorporated Ltd Llc, New York-based fund reported 2.58M shares.

Since May 9, 2017, it had 0 insider purchases, and 2 insider sales for $5.11 million activity. MARTIN JOHN C also sold $4.78 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, June 1. 9,943 shares were sold by Cogan John Francis, worth $668,667.

Joel Greenblatt decreased its stake in Gilead Sciences Inc (GILD) by 20.49% based on its latest 2017Q2 regulatory filing with the SEC. Gotham Asset Management Llc sold 248,315 shares as the company’s stock declined 8.05% while stock markets rallied. The hedge fund run by Joel Greenblatt held 963,721 shares of the health care company at the end of 2017Q2, valued at $68.21M, down from 1.21M at the end of the previous reported quarter. Gotham Asset Management Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $95.16 billion market cap company. The stock rose 0.68% or $0.49 reaching $72.87. About 3.63 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since November 7, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Gotham Asset Management Llc, which manages about $5.96 billion and $7.13B US Long portfolio, upped its stake in Alphabet Inc by 22,312 shares to 28,897 shares, valued at $26.87M in 2017Q2, according to the filing. It also increased its holding in Caci Intl Inc (NYSE:CACI) by 65,754 shares in the quarter, for a total of 84,325 shares, and has risen its stake in Mueller Wtr Prods Inc (NYSE:MWA).

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Gilead Sciences: More Of The Same, Long Thesis Holds” on October 31, 2017, also Fool.com with their article: “What happened with Gilead Sciences this quarter?” published on October 26, 2017, Fool.com published: “Which stock is the better buy?” on October 24, 2017. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “The Math Behind the Gilead’s Recent Merger” published on October 18, 2017 as well as Fool.com‘s news article titled: “What’s Behind Gilead Sciences Inc.’s $7.8 Billion Slide in October?” with publication date: November 02, 2017.

Gilead Sciences, Inc. (NASDAQ:GILD) Ratings Coverage

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 104 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Friday, July 21 by BMO Capital Markets. The rating was initiated by Oppenheimer with “Outperform” on Thursday, February 11. Maxim Group maintained the shares of GILD in report on Tuesday, May 30 with “Hold” rating. Robert W. Baird maintained the shares of GILD in report on Monday, October 16 with “Buy” rating. Jefferies maintained the shares of GILD in report on Wednesday, October 4 with “Hold” rating. Bank of America upgraded the stock to “Neutral” rating in Friday, January 15 report. Jefferies initiated the stock with “Hold” rating in Wednesday, September 9 report. On Friday, July 24 the stock rating was maintained by Piper Jaffray with “Overweight”. The stock has “Buy” rating by Needham on Wednesday, July 29. The firm has “Hold” rating given on Friday, July 29 by Argus Research.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.